These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 26461500)

  • 21. The Expert Consensus Guideline Series. Treatment of behavioral emergencies.
    Allen MH; Currier GW; Hughes DH; Reyes-Harde M; Docherty JP;
    Postgrad Med; 2001 May; (Spec No):1-88; quiz 89-90. PubMed ID: 11500996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial response to antipsychotic treatment: the patient with enduring symptoms.
    Emsley RA
    J Clin Psychiatry; 1999; 60 Suppl 23():10-3. PubMed ID: 10625194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment adherence in schizophrenia and schizoaffective disorder.
    Goff DC; Hill M; Freudenreich O
    J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive psychosocial therapies for the treatment of schizophrenia.
    Patterson TL; Leeuwenkamp OR
    Schizophr Res; 2008 Mar; 100(1-3):108-19. PubMed ID: 18226500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders.
    Helldin L; Kane JM; Karilampi U; Norlander T; Archer T
    Schizophr Res; 2007 Jul; 93(1-3):160-8. PubMed ID: 17395430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission.
    Alenius M; Hammarlund-Udenaes M; Hartvig P; Sundquist S; Lindström L
    Compr Psychiatry; 2009; 50(5):453-62. PubMed ID: 19683616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions to improve antipsychotic medication adherence: review of recent literature.
    Dolder CR; Lacro JP; Leckband S; Jeste DV
    J Clin Psychopharmacol; 2003 Aug; 23(4):389-99. PubMed ID: 12920416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating treatment with rehabilitation for persons with major mental illnesses.
    Kopelowicz A; Liberman RP
    Psychiatr Serv; 2003 Nov; 54(11):1491-8. PubMed ID: 14600308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
    de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
    Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug treatment of functional psychotic disorders].
    Bridler R; Umbricht D; Hell D
    Praxis (Bern 1994); 2001 May; 90(22):981-6. PubMed ID: 11450186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concordance of patient and clinical ratings of symptom severity and change of psychotic illness.
    Rabinowitz J; Levine SZ; Medori R; Oosthuizen P; Koen L; Emsley R
    Schizophr Res; 2008 Mar; 100(1-3):359-60. PubMed ID: 18077138
    [No Abstract]   [Full Text] [Related]  

  • 35. Patient perceived participation in decision making on their antipsychotic treatment: Evidence of validity and reliability of the COMRADE scale in a sample of schizophrenia spectrum disorders.
    Pérez-Revuelta J; Villagrán-Moreno JM; Moreno-Sánchez L; Pascual-Paño JM; González-Saiz F
    Patient Educ Couns; 2018 Aug; 101(8):1477-1482. PubMed ID: 29606551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic principles for differential therapy of psychoses].
    Hell D; Bridler R
    Praxis (Bern 1994); 2001 May; 90(22):975-80. PubMed ID: 11450185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cognitive deficits in schizophrenia and other psychotic disorders].
    Fagerlund B; Glenthøj BY
    Ugeskr Laeger; 2008 Nov; 170(46):3770-2. PubMed ID: 19014728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current treatment of psychosis].
    Jørgensen P
    Ugeskr Laeger; 2001 Apr; 163(14):1975-7. PubMed ID: 11307353
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.